Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ALL vs GSK✓SelectedUSD · GSKALL vs GSK performance historyLatest closeAs of+0.07%11/19
Stock and ETF performance explorer

ALL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+360.4%
GSK return
+97.7%
Excess return
+262.7%
Maximum drawdown
-41.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.1%-1.6%+1.6%+0.6%
7D0.0%-4.7%+4.7%+1.7%
30D+6.7%-4.7%+11.4%+8.4%
3M+3.1%-8.8%+11.9%+6.2%
6M+19.9%-4.6%+24.5%+21.3%
YTD+30.0%+1.0%+29.0%+28.4%
1Y+29.5%+6.9%+22.7%+25.3%
3Y+111.3%+52.5%+58.8%+74.8%
5Y+168.2%+40.3%+128.0%+124.7%
All+360.4%+97.7%+262.7%+245.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling